GKSL NSE filing

Gujarat Kidney And Super Speciality: Company Secretary & Compliance Officer Resigns

The RealCase readLow impact Neutral

Mrs. Niki Paresh Tiwari has resigned as Company Secretary and Compliance Officer of Gujarat Kidney And Super Speciality Limited. Her last day of employment will be March 27, 2026. The company is actively searching for a replacement.

Why it matters

The resignation of the Company Secretary and Compliance Officer is a standard corporate event. The company has indicated that a replacement process is underway, mitigating potential disruption.

The market read

The resignation of a key managerial personnel is a routine event and does not inherently carry a positive or negative financial implication for the company.

Gujarat Kidney And Super Speciality Limited announced the resignation of Mrs. Niki Paresh Tiwari from her positions as Company Secretary and Compliance Officer, effective immediately. The resignation is due to Mrs. Tiwari pursuing career opportunities outside the organization.

The management of the company has accepted the resignation, and her relieving date is set as March 27, 2026. The company has initiated the process to identify and appoint a suitable candidate for the role, which will be finalized within the stipulated timelines as per SEBI (LODR) Regulations. Further disclosures regarding the appointment will be made at the appropriate time.

Filing to action

What to do with a filing like this

Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.

View original filing